Maruto Sangyo Co., Ltd (7894) Stock Price

Maruto Sangyo's main business is the manufacturing and sales of packaging materials, as well as the purchase and resale of such materials. The company manufactures composite films and single-layer films, and also sources and sells packaging materials such as films and containers.

Its primary customers are pharmaceutical manufacturers and major printing and packaging companies, including Hisamitsu Pharmaceutical, which purchases the company's films. The company's revenue is primarily driven by sales of its own manufactured films, with sourcing and resale operations, as well as import-export activities through group companies in Hong Kong and Thailand, serving as important additional revenue streams.

The business is divided into two segments: a manufacturing division and a trading division focused on sourcing and resale. The manufacturing division handles the production of composite films and film bag manufacturing processes. The company offers a full product line including composite films, single-layer films, and containers, with group operations divided by process and region to support sales and outsourced processing.

The company aims for stable and sustainable growth and profit generation as its management objectives, though it does not disclose specific numerical targets. Accordingly, the core of its growth strategy is to strengthen sales of its in-house manufactured composite films and single-layer films, while stabilizing its revenue base through dual operations combining manufacturing with trading activities. Currently, sales of proprietary products form the revenue pillar, with sourcing and resale operations as well as import-export activities through group companies in Hong Kong and Thailand positioned as important income sources. Given the external environment of sustained high raw material and energy prices and yen weakness, the company prioritizes balancing production capacity expansion with quality maintenance.

Priority investment areas include production equipment and manufacturing technology. The company is actively promoting the adoption of advanced production techniques utilizing state-of-the-art equipment. Specifically, it is advancing production capacity expansion, process efficiency improvements including bag-making operations, and the establishment of a rapid and high-quality supply system. As it serves major customers with strict quality requirements, such as pharmaceutical manufacturers including Hisamitsu Pharmaceutical, the company emphasizes differentiation through quality control and short lead-time responsiveness to strengthen customer trust.

Regarding new market development and business expansion, the company combines its two segments—the existing manufacturing division and trading division—to expand sales channels through regional sales strategies and outsourced processing. Leveraging group companies in Hong Kong and Thailand as footholds, the company strengthens transactions across Asia and optimizes its supply chain including import-export operations, while considering domestic demand recovery and inbound tourism trends. In parallel, to address external uncertainties, the company is advancing procurement stabilization, cost management, and price adjustment strategies.

In technological innovation, the company pursues enhanced product competitiveness through improved composite film functionality and automation and labor-saving measures in production processes. By combining research and development with capital investment, the company focuses on material development that enhances basic packaging functions such as barrier and durability properties, as well as quality stabilization in manufacturing. This aims to expand orders in high-value-added sectors such as pharmaceuticals, with differentiation achieved through rapid supply and high quality simultaneously.